Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Sesterhenn

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Prostate Cancer and Prostatic Diseases|December 10, 2003
p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 proteinG L Griewe, R C Dean, W Zhang, et al.
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.
Studies in Health Technology and Informatics|September 8, 2000
Investigating 3D tumor distribution for optimized diagnosis of prostate cancerJ Zeng, J J Bauer, X Yao, et al.
Cancer Research|June 5, 2001
Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in ChinaA P Chokkalingam, K A McGlynn, Y T Gao, et al.
Cancer Research|October 4, 2000
Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in ChinaA W Hsing, Y T Gao, G Wu, et al.
The Prostate|July 1, 1995
Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection ProjectF K Mostofi, G P Murphy, C Mettlin, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2009
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion statusK Mwamukonda, Y Chen, L Ravindranath, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2005
Quantitative expression profile of PSGR in prostate cancerL L Xu, C Sun, G Petrovics, et al.
The Prostate|February 15, 1997
Mutations of the p16 gene product are rare in prostate cancerJ P Gaddipati, D G McLeod, I A Sesterhenn, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the distribution of prostate cancer using three-dimensional computer simulationM B Opell, J Zeng, J J Bauer, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Prostate Cancer and Prostatic Diseases|December 10, 2003
p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 proteinG L Griewe, R C Dean, W Zhang, et al.
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.
Studies in Health Technology and Informatics|September 8, 2000
Investigating 3D tumor distribution for optimized diagnosis of prostate cancerJ Zeng, J J Bauer, X Yao, et al.
Cancer Research|June 5, 2001
Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in ChinaA P Chokkalingam, K A McGlynn, Y T Gao, et al.
Cancer Research|October 4, 2000
Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in ChinaA W Hsing, Y T Gao, G Wu, et al.
The Prostate|July 1, 1995
Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection ProjectF K Mostofi, G P Murphy, C Mettlin, et al.
Prostate Cancer and Prostatic Diseases|July 15, 2009
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion statusK Mwamukonda, Y Chen, L Ravindranath, et al.
Prostate Cancer and Prostatic Diseases|October 19, 2005
Quantitative expression profile of PSGR in prostate cancerL L Xu, C Sun, G Petrovics, et al.
The Prostate|February 15, 1997
Mutations of the p16 gene product are rare in prostate cancerJ P Gaddipati, D G McLeod, I A Sesterhenn, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Investigating the distribution of prostate cancer using three-dimensional computer simulationM B Opell, J Zeng, J J Bauer, et al.
Pageof 11